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Interest in how the gastrointestinal microbiota (GM) stimulates 
the immune system and thereby contributes to the development 
of immunologic and inflammatory diseases has increased during 
recent years. In several animal models, including those for type 1 
diabetes,20,21,29 type 2 diabetes,4,52 and colitis,45 disease expression is 
influenced strongly by the GM.6,32 The effect of the GM on animal 
models has been demonstrated by using antibiotic-treated6 or 
germ-free mice, which can express increased or decreased disease 
incidence depending on the model.32 Germ-free conditions are 
rather dramatic compared with the smaller deviations between 
the GM of individuals observed in mice purchased from com-
mercial breeders,26 as not only the complete absence of microbes, 
but also the balance between different species affect the immune 
system, for example, gram-positive bacteria from human GM 
induce considerably higher levels of the Th1 cytokines IL12 and 
TNFα in human neonatal cells than do gram-negative bacteria;32 
Th17 cells accumulate only in the presence of some members of 
segmented filamentous bacteria;27 and regulatory T cells may in-
crease in number because of the presence of specific species of 
lactobacilli and Bifidobacteria.13,34 In addition, the composition of 
the GM strongly affects disease development in humans.46
Variations in the GM can be investigated using by a molecular 
fingerprinting method, denaturing gradient gel electrophoresis, 
and a mathematical model, principal component analysis (PCA). 
In denaturing gradient gel electrophoresis, PCR products of simi-
lar size are separated on a gel with a denaturing gradient, result-
ing in a pattern of bands in which each band ideally represents a 
bacterial population.17 To perform PCA on the band patterns, the 
areas of the highest discrimination are calculated—that is, each 
sample is scored quantitatively on a scale that expresses how dif-
ferent the samples are. The components with the highest, second-
highest, and third-highest discrimination can then be put into a 
3D plot to illustrate whether they cluster according to groups or 
just spread randomly in the plot.49 In theory, the plot can involve 
an infinite number of axes, but for visual reasons, those 3 with the 
highest discriminatory capability typically are chosen, because 
significant differences, if any, most likely will be found on one of 
these. The PC values on the axes of the PCA plot are arbitrary, but 
can be used for calculating differences between groups of band 
patterns (that is, GM profiles) or in a regression analysis to show 
whether GM composition predicts other parameters.
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guidelines,38 arrived at the facility (LEO Pharma, Ballerup, Den-
mark) and were allowed to acclimate for 9 d. BALB/cA mice were 
chosen for the strain’s ability to produce robust cellular and hu-
moral immune responses.
Mice were housed in an experimental facility with restricted 
access, quarantine rules, and control of incoming objects in Eu-
rostandard type III transparent cages (Techniplast, Varese, Italy) with 
aspen bedding (Tapvei, Kortteinen, Finland) in an individually 
ventilated Scantainer (Scanbur A/S, Karlslunde, Denmark) with 
a minimum of 20 air exchanges hourly. Mice received commercial 
diet (no. 1324, Altromin, Lage, Germany) and bottled tap water 
without further treatment or additives ad libitum. Cages were 
enriched with Fun Tunnels (size, mini; Lillico Biotechnology, 
Hookwood, UK), Des Res. Mouse House (Lillico Biotechnology), 
nesting material (Sizzle-nest, NOVA-SCB, Sollentuna, Sweden) 
and aspen bricks (size, M; Tapvei). Bedding, feed, and enrich-
ment materials were not sterilized. Temperature was 20 to 23 °C, 
relative humidity was 30% to 60%, and lights were on from 0600 
to 1800. Three groups of 10 mice each were used: an oxazolone 
group, a vehicle-only control group, and a baseline group. Animal 
welfare during the study period was monitored by systematic 
observations of body weight, piloerection, and general condition.
Induction of skin inflammation. Mice in the oxazolone group 
were sensitized once on day −7 by topical application of 20 µL 
0.8% oxazolone (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one; 
Sigma-Aldrich, St Louis, MO) dissolved in acetone (Emsure, Mer-
ck Chemicals, Darmstadt, Germany) with a pipette on both sides 
of the right ear while they were restrained by scruffing of the 
neck. After a week, challenges comprising 20 µL 0.4% oxazolone 
were performed on days 0, 3, 7, 10, 12, 14, 16, 18, and 20, each time 
by using a freshly prepared solution (Figure 1). Concurrently, 
on days 10 through 21, mice in the oxazolone and vehicle-only 
groups were sham-treated once daily with 20 µL acetone to mimic 
the model when it is used for efficacy testing; in the way, we en-
sured that test results could be compared with previous inhouse 
studies. Mice in the vehicle-only group were sham-sensitized, 
sham-challenged, and sham-treated with 20 µL acetone topically 
on both sides of the left and right ear, according to the same time 
scheme as that for the oxazolone group. The baseline group was 
not sensitized, challenged, or treated. The dosage regimen was 
determined based on inhouse experience and previous work with 
the oxazolone-induced dermatitis model.35,48
TEWL and ear thickness. TEWL was measured by using a Va-
poMeter (DelfinTechnologies, Kuopio, Finland) on the right ear on 
days −7, 10, and 20 before dosing. Room temperature and relative 
humidity were recorded on each day of TEWL measurements, be-
cause these environmental factors influence the VapoMeter’s per-
formance.11 Because temperature and humidity remained within 
the normal ranges for the facility, VapoMeter measurements were 
considered valid. Ear thickness was recorded before dosing on 
the right ear on days 10, 12, 14, 17, 18, and 21 by using an Abso-
lute Digimatic Micrometer (model 547–313, Mitutoyo, Kawasaki, 
Japan); the same person performed all measurements to ensure 
consistent pressure and placement of the micrometer.
Plasma cytokines and CRP. Blood was collected terminally 
by cardiocentesis of mice under isoflurane anesthesia (Baxter, 
Søllerød, Denmark) on day 0 (baseline group) and day 21 (ox-
azolone and vehicle-only groups), stabilized in 1.5 mL EDTA an-
ticoagulant-coated test tubes (Eppendorf, Eppendorf, Germany), 
kept on wet ice, and centrifuged for 10 min at 1000 × g and 4 °C. 
If variations in GM composition are correlated with disease ex-
pression in mice, improved control of the GM may be a potential 
tool for reducing group sizes in animal studies. The composi-
tion of the GM varies substantially between even inbred mice, 
which may have an interindividual similarity in their GM of less 
than 80%26 due to both genetic and environmental reasons.25,42 
It is therefore reasonable to assume that if variation in the GM 
composition of mouse models can be better controlled, it also will 
be possible to reduce interindividual variation and thereby group 
sizes in mouse studies.
Atopic dermatitis (AD) is an inflammatory, chronically relaps-
ing, noncontagious and pruritic eczema10 characterized by xerosis, 
pruritus, and cutaneous inflammation, which affects up to 20% of 
children in some geographic areas.55 Several animal models are 
available for human AD. Nc/Nga mice spontaneously develop 
AD-like skin lesions, but only under conventional housing condi-
tions,36 thereby indicating a correlation with GM composition. 
Other models involve topical administration of haptens such as 
oxazolone,28 a potent contact allergen; a single topical application 
of oxazolone provokes T cell-mediated delayed type hypersensi-
tivity. During the sensitization phase, the antigen is phagocytized 
and processed by Langerhans cells and other dedicated antigen 
presenting cells, which in turn migrate to skin-draining lymph 
nodes, where they present the antigen to naïve CD4+ T cells.19 
IL12 produced by Langerhans cells results in a differentiation 
toward a Th1 cytokine milieu.12 During the elicitation phase, the 
primed Th1 cells patrol the skin and become activated on meeting 
the antigen and subsequently initiate an inflammatory response.19 
After 9 or 10 challenges with oxazolone on mouse skin, a phe-
notype evolves with multiple features resembling human AD.35 
During the chronic phase of oxazolone-induced murine skin in-
flammation, a Th2-associated cytokine profile with high levels of 
IL10 dominates in contrast to the early Th1-dominating response 
with high levels of TNFα and IL12.18,54 This feature makes this 
murine model somewhat analogous to early stages of human AD, 
in which Th2 cytokines dominate in the acute phase, whereas Th1 
cytokines dominate in the chronic phase.23,33 Clinically, the oxa-
zolone model is characterized by monitoring the thickness of the 
edema-swollen pinnae (ear thickness) and transepidermal water 
loss (TEWL), which is a well-established measure of skin barrier 
function in human AD patients.1,16
The GM of children with AD is different and less diverse than 
that of nonallergic children.5 Differences in the GM of fecal sam-
ples of 1-mo-old infants have been shown to precede manifesta-
tions of atopic symptoms later in life;43 other studies have also 
linked GM to the development of atopic diseases.24,30,53We, hy-
pothesized that the composition of the GM influences the devel-
opment of AD in the oxazolone mouse model.
Materials and Methods
Mice. Housing, maintenance, and experimental procedures 
were conducted in accordance with the European Convention 
for the Protection of Vertebrate Animals used for Experimental 
and Other Scientific Purposes (ETS 123 of 1986)9 and The Danish 
Animal Experimentation Act (LBK no. 1306 of 23/11/2007).37 The 
study was approved by the Animal Experiments Inspectorate, 
Ministry of Food, Agriculture and Fisheries, Denmark.
Female BALB/cABomTac mice (n = 30; age, 7 wk; Taconic, Ejby, 
Denmark), screened for infectious agents according to the Mu-
rine Pathogen-Free health standard of the breeder and FELASA 
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with a 30-s pause between sessions to avoid heating. A maximal 
temperature of 4 °C during homogenization was maintained by 
using a Cryolys cooling apparatus (Bertin Technologies). The ho-
mogenized tissue was centrifuged for 15 min at 15,000 × g and 
the supernatant used for cytokine analysis. Levels of IFNγ, IL1β, 
IL2, IL4, IL5, keratinocyte-derived chemokine/growth-related 
oncogene (KC/GRO), IL10, IL12 (total), and TNFα were analyzed 
by using the Multispot Mouse Th1/Th2 9plex Assay (Meso Scale 
Discovery, Gaithersburg); results were read on a SECTOR Imager 
6000 (Meso Scale Discovery). The plate was blocked for 1 h by 
using 150 µL Calibrator Buffer (Meso Scale Discovery) with vigor-
ous shaking at room temperature and then washed 3 times with 
150 µL PBS containing 0.05% Tween 20 (Roche Diagnostics) per 
well. Calibrator-treated sample (25 µL) was added to each well, 
and the plate was incubated at room temperature with shaking 
for 2 h; 25 µL of 1× Detection Antibody (Meso Scale Discovery) 
was added to each well, the plate was incubated with shaking for 
2 h at room temperature, wells were washed 3 times with 150 µL 
PBS containing 0.05% Tween 20 per well, and 150 µL 2× Read Buf-
fer (Meso Scale Discovery) was added to each well. The biopsies 
preserved in formaldehyde were embedded in paraffin, sliced, 
and stained with hematoxylin and eosin, and the type of inflam-
mation was evaluated.
Fecal and cecal samples. Fecal samples were collected on days 
−7, 10, and 21 by letting mice defecate spontaneously into an 
autoclaved 1.5-mL test tube (Eppendorf) during restraint. Ce-
cal samples were collected on day 0 (baseline group) and day 21 
(oxazolone and vehicle-only groups) by aseptic excision immedi-
ately after euthanasia; samples were put in autoclaved 1.5-mL test 
tubes (Eppendorf). Fecal and cecal samples were placed immedi-
ately on wet ice and stored at −80 °C within 30 min of collection. 
DNA was extracted by using the QIAamp DNA Stool Mini Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s pro-
tocol for isolation of DNA for pathogen detection. Before extrac-
tion, cecal tissue samples were homogenized by using a FastPrep 
Plasma (70 µL) was isolated and stored at –80 °C. Three blood 
samples from the oxazolone group were lost due to technical is-
sues. Levels of granulocyte–macrophage colony-stimulating fac-
tor, IFNγ, IL1α, IL1β, IL2, IL4, IL5, IL6, IL10, IL12(p70), IL17, and 
TNFα in plasma were measured by using the Mouse Th1/Th2 
10plex FlowCytomix Multiplex kit (Bender Medsystems, Vienna, 
Austria) and the Mouse IL1β and IL12(p70) Simplex kits (Bender 
Medsystems). The assay was performed according to the manu-
facturer’s instructions except that we scaled down the volumes of 
plasma and reagents by 50% due to limited amounts of plasma. 
The analysis was run on a FACSCanto flow cytometer (BD Bio-
sciences, Brøndby, Denmark), and data were processed by us-
ing FlowCytomix Pro 2.3 software (Bender Medsystems). CRP in 
plasma was evaluated by using the CRP (Mouse) ELISA kit (DRG 
Diagnostics, Marburg, Germany) according to the manufacturer’s 
instructions; results were read on a Sunrise microplate absorbance 
reader (Tecan, Männedorf, Switzerland).
Ear tissue cytokines and histology. The noninflamed left and 
right pinnae of mice in the vehicle-only group and the inflamed 
right pinnae of mice in the oxazolone group were sampled on day 
21 by using an 8-mm disposable dermal biopsy punch (Miltex 
GmbH, Ratingen, Germany). A 3-mm punch biopsy (Miltex) for 
histology was taken from the middle of the 8-mm biopsy and 
preserved in formaldehyde (10%). The remaining biopsy tissue 
was snap-frozen in liquid nitrogen in a cryotube (Nunc, Roskilde, 
Denmark) and stored at −80 °C. On the day of analysis, the biop-
sies were kept cold constantly. Lysis buffer consisting of 10.6 mL 
1×PBS without calcium and magnesium (Invitrogen, Life Tech-
nologies, Carlsbad), 1 Complete EDTA-free Protease Inhibitor 
Cocktail tablet (Roche Diagnostics, Hvid-ovre, Denmark), 400 µL 
NP40 detergent, and 100 µL 1mM Na3VO4
+ (a phosphatase inhibi-
tor) was prepared. Each biopsy was placed in 200 µL lysis buf-
fer in precooled Precellys (Bertin Technologies, Orleans, France) 
tubes with ceramic beads and homogenized on a Precellys 24 
instrument (Bertin Technologies) at 6800 rpm twice for 15 s each, 
Figure 1. Study timeline. The oxazolone group was sensitized (0.8% oxazolone) on day –7 and challenged (0.4% oxazolone) on days 0, 3, 5, 7, 10, 12, 
14, 16, 18, and 20. The vehicle-only group was sham-sensitized with acetone on day –7 and sham-challenged on days 0, 3, 5, 7, 10, 12, 14, 16, 18, and 
20. Both groups were sham-treated with acetone on days 10 through 21. Transepidermal water loss (TEWL) was measured on days −7, 10, and 20. Ear 
thickness was measured on days 10, 12, 14, 17, 18, and 21. Feces were sampled on days −7, 10, and 21. Terminal samples (plasma, cecum, and ear tissue) 
were harvested on day 0 (baseline group) and day 21 (oxazolone and vehicle groups).
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merase (5 Prime), 10 pmol of each primer, 1 µL bovine serum 
albumin (5 µl/mL; Sigma-Aldrich), approximately 50 ng DNA, 
and sufficient ultrapure water to bring the reaction volume to 50 
µL. PCR amplification was performed on a GeneAmp PCR Sys-
tem 9700 (Applied Biosystems, Life Technologies, Carlsbad, CA) 
with initial denaturation at 95 °C for 5 min followed by 30 cycles 
of denaturation at 95 °C for 30 s, annealing at 60 °C for 30 s, and 
extension at 72 °C for 40 s and a final elongation step at 72 °C for 
10 min. The PCR product (approximately 230 bp) was checked by 
electrophoresis on a 2% agarose gel at 100 to 120 V for 20 min. The 
gel was stained with ethidium bromide (4 µg/mL) for 10 min and 
visualized on an AlphaImager HP (Cell Biosciences, Santa Clara). 
PCR products were separated by denaturing gradient gel electro-
phoresis using the PhorU-2 system (INGENY, Amundsenweg, 
Netherlands) according to the manufacturer’s instructions. The 
acrylamide concentration in the gel was 9%, and the linear dena-
turation gradient was 30% to 65%. For each well, 20 µL of the PCR 
product was mixed with 3.75 µL 6× DNA loading dye (Fermentas, 
Thermo Fisher Scientific, GlenBurnie, MD) and loaded on the gel. 
In addition, a standard consisting of mixed PCR products repre-
senting mouse fecal samples with diverse bands was loaded to 
enable accurate alignment of lanes and bands within and between 
gels. Electrophoresis was performed in 0.5×TAE buffer at 60 °C 
for 16 h at 120 V. The gels were stained by using a 1:10,000 SYBR 
Gold solution (Invitrogen, Life Technologies) in 0.5×TAE for 1 h 
and photographed under UV transillumination (EDAS, Eastman 
Kodak, Rochester, NY).
Statistical analysis. Denaturing gradient gel electrophoresis 
profiles were analyzed by using BioNumerics version 4.5 (Ap-
plied Maths, Sint-Martens-Latem, Belgium) to calculate the Dice 
coefficient of similarity (with a band position tolerance and opti-
mization of 1%) and to apply the unweighted pair-group method 
with an arithmetic averages clustering algorithm for dendrogram 
construction. 3D principal component analysis (PCA) plots were 
made by band-matching of data from denaturing gradient gel 
electrophoresis, and values of PC1, PC2, and PC3 were obtained 
from plots and correlated with clinical parameters (TEWL, ear 
thickness, ear tissue cytokines, plasma cytokines, and CRP). With-
in the oxazolone group, regressions were made between the com-
bined PC1–PC2–PC3 and each clinical data set. Regressions were 
checked for validity by removal of a random sample of data fol-
lowed by regression analysis of the remaining data. Regressions 
also were performed for correlations between cytokine data and 
TEWL as well as ear thickness. Clinical parameters and PC values 
were compared between groups by ANOVA in GraphPad Prism 
version 5.04 for Windows (GraphPad Software, La Jolla, CA). All 
data were tested for normality by the D’Agostino and Pearson 
omnibus normality test. For normally distributed data, a Student 
t test or one-way ANOVA was used, followed by the Bonferroni 
multiple comparison test. For data that did not meet normality 
criteria, the Mann–Whitney U test or Kruskal–Wallis one-way 
ANOVA was used, followed by the Dunn multiple comparison 
test. Regressions were performed by using Statistical Software 
version 16.1.1 (Minitab, State College, PA). The confidence level 
was 95% for all tests. All parametric values are reported as mean 
± 1 SD.
Results
The oxazolone group showed overt signs of inflammation, 
namely redness and swelling, along with an increase in TEWL 
FP120 Cell Disrupter (QBiogene, MP Biomedicals, Ilkirch, France) 
for 45 s at 6 m/s. Quality and concentration of the extracted DNA 
was checked on a NanoDrop 1000 Spectrophotometer (Thermo 
Scientific). DNA extracts from fecal and cecal samples were stored 
at −40 °C.
Gut microbiota characterization. The V3 region of the bacterial 
16S rRNA gene was amplified by PCR using the universal prim-
ers PRBA338f (Eurofins MWG Operon, Ebersberg, Germany) and 
PRUN518r41 (Eurofins MWG Operon). All reactions were done 
in a 50-µL volume containing 5 µL 10× HotMasterTaq Buffer (5 
Prime, Hamburg, Germany), 12 µL dNTPs (1.25 mM, Bioline, 
Risskov, Denmark), 0.25 µL 1.25 U HotMasterTaq DNA Poly-
Figure 2. Transepidermal water loss (TEWL; g/m2/h) in the right ear 
(mean, SD) of mice dosed with vehicle or oxazolone showing signifi-
cantly (+, P < 0.0001) higher TEWL in the oxazolone group on days 10 
and 20.
Figure 3. Ear thickness (mm) on the right ear (mean, SD) of mice dosed 
with vehicle or oxazolone. Compared with that in the vehicle-only 
group, ear thickness is greater (+, P < 0.0001) in the oxazolone group at 
all time points (days 10, 12, 14, 17, 19, and 21).
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indirectly in the form of wounds or directly during cageside ob-
servations.
Plasma levels of IL6 were higher (P < 0.01) in the baseline group 
compared with the oxazolone group (Figure 6). CRP was high-
er (P < 0.01) in the oxazolone group (44.88 ng/mL) compared 
with the baseline (38.68 ng/mL) and vehicle-only (38.60 ng/mL) 
groups (Figure 7). No differences were detected between groups 
with regard to plasma levels of granulocyte–macrophage colony-
stimulating factor, IFNγ, IL1α, IL1β, IL2, IL4, IL5, IL10, IL12(p70), 
IL17, and TNFα (Figure 6). There was significant correlation be-
tween the combined PC1–PC2–PC3 of the fecal samples from day 
−7 and the final levels of the ear tissue cytokines IFNγ (P < 0.001, 
r2 = 0.93), IL1β (P < 0.01, r2 = 0.83), IL4 (P < 0.05, r2 = 0.74), IL8 (P 
< 0.01, r2 = 0.88), IL10 (P < 0.01, r2 = 0.86), IL12 (P < 0.05, r2 = 0.71), 
and TNFα (P < 0.01, r2 = 0.87; Table 1). However, the correlation 
with IL4 disappeared by removing a random data set. There was 
also significant correlation between the combined PC1–PC2–PC3 
of the cecal microbiota and TEWL (P < 0.05, r2 = 0.76) as well as 
on days 10 and 20 (P < 0.0001 for both days; Figure 2). On day 21, 
after 10 oxazolone challenges, epidermal ear thickness (mean ± 1 
SD) in the oxazolone group was 0.63 ± 0.11 mm compared with 
0.16 ± 0.01 mm in the vehicle-only group (P < 0.0001; Figure 3), 
and all ear tissue cytokines were higher in the oxazolone group (P 
< 0.001 for KC/GRO; P < 0.0001 for IL1β, IL2, IL4, IL5, IL10, IL12, 
INFγ, and TNFα; Figure 4). Histologically, oxazolone-treated ears 
were characterized by severe, chronic–active, diffuse, suppura-
tive dermatitis in both the epidermal and dermal layers. A mixed 
infiltration of mainly granulocytes with moderate numbers of 
lymphocytes, mast cells, macrophages, and eosinophils was pres-
ent. Hyperkeratosis and parakeratosis in the stratum corneum, 
hypergranulosis in the stratum granulosum and hyperplasia of 
the stratum spinosum (acanthosis), and intercellular epidermal 
edema (spongiosis) were prominent (Figure 5). No deviations 
from normal were noted regarding body weight, piloerection, 
and general behavior. Scratching behavior was not seen, either 
Figure 4. Cytokine levels (mean ± 1 SD) in ear tissue on day 21 in mice dosed with vehicle or oxazolone. All cytokines are higher (#, P < 0.001 for KC/
GRO; +, P < 0.0001 for IL1β, IL2, IL4, IL5, IL10, IL12, INFγ, and TNFα) in the oxazolone group.
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and TNFα; the antiinflammatory cytokines IL4 and IL10; and the 
chemokine KC/GRO paralleled the degree of variation in the 
GM before skin inflammation was induced. Several studies have 
demonstrated that the GM is a factor in the development of AD 
in humans,43 but to our knowledge this study shows for the first 
time that GM composition can be used to predict parameter ex-
pression in an animal model of AD. Our findings, therefore, add 
to the increasing awareness that variation in GM accounts for 
much of the variation observed in such inflammatory models.6 
Other models, including several transgenic and knockout mouse 
strains, develop various types of spontaneous dermatitis,28 and 
it may be fruitful to investigate the correlation between AD and 
GM in these systems. Another option might be to inoculate mice 
with a specific GM that has particular relevance for the model.22
In the current study, GM composition seemed to have the great-
est effect on the cytokine levels in samples of ear tissue, whereas 
other parameters—ear thickness and TEWL—did not correlate 
with either GM or the inflammatory response in the ear. In this 
context, it should be remembered that the oxazolone-treated 
mouse model is chemically induced, and human patients with 
AD do not develop disease as a response to having a hapten ap-
plied repeatedly to the skin. Our study suggests that factors other 
than inflammation contribute markedly to the macroscopic signs 
of dermatitis, and these factors very likely reflect the repeated ap-
plication of a chemical to the skin.
The composition of the fecal GM varied during the experimen-
tal period in the oxazolone-treated mice but not in the vehicle-
ear thickness (P < 0.05, r2 = 0.80) and between ear thickness and 
TEWL (P < 0.05, r2 = 0.44), but none of the cytokines in either plas-
ma or ear tissue correlated with ear thickness or TEWL.
The cecal GM was clearly separated into 2 groups by PC1 con-
sisting of the oxazolone group compared with the vehicle-only 
and baseline groups taken together (P < 0.01; Figure 8), whereas 
the vehicle-only group did not cluster significantly different from 
the baseline group. The fecal GM in the oxazolone group changed 
during the study period, leading to significantly (P < 0.0001) dif-
ferent clustering of samples by PC1 between days −7 and 21; this 
change in GM was not observed in the vehicle group (Figure 9).
Discussion
Topical administration of oxazolone induced immense local 
inflammation in the pinnae of our mice. TEWL and ear thickness 
increased in the oxazolone-treated mice, which also showed clear 
responses in all ear tissue cytokine levels compared with those 
of the vehicle-only group. The cytokine picture was a mixture 
of proinflammatory responses, including those in IL1, IL6, IL12, 
TNFα, and IFNγ, and antiinflammatory responses, such as those 
involving IL4 and IL10. These results suggest that this model of 
atopic dermatitis is in transition from an acute to chronic disease 
phase.
The initial composition of the fecal microbiota and the cytokine 
response in the ear tissue of oxazolone-treated mice related in 
that levels of the proinflammatory cytokines IFNγ, IL1β, IL12, 
Figure 5. Cross-sections of pinnae from 1 mouse each from (A) the vehicle-only group and (B) the oxazolone group. (A) Normal epidermis, dermis, and 
subcutis. (B) Hyperkeratosis and parakeratosis in stratum corneum, hypergranulosis in stratum granulosum, and hyperplasia of stratum spinosum 
(acanthosis); intercellular epidermal edema (spongiosis), and mixed infiltration in both epidermis and dermis consisting mainly of neutrophil granu-
locytes. *, Auricular cartilage. Hematoxylin and eosin stain; magnification, 10×.
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suggest that the ear inflammation may have triggered a stress 
response in the mice, which subsequently caused perturbations in 
GM during the study period. Despite the lack of clinical signs of 
decreased animal welfare, we cannot exclude the possibility that 
treated mice. In cecal samples, the GM of oxazolone-treated mice 
differed from those of the vehicle-treated and baseline mice, 
which did not differ from each other, even though the baseline 
and vehicle-only samples were obtained 20 d apart. These data 
Figure 6. Plasma cytokine levels (mean ± 1 SD) in nondosed (baseline), vehicle- and oxazolone-dosed mice measured on day 21. IL6 is higher (†, P < 
0.01) in the baseline group than in the oxazolone group. For IL1α, IL1β, IL2, IL4, IL5, IL10, IL12(p70), IL17, INFγ, TNFα and granulocyte–macrophage 
colony-stimulating factor (GM-CSF) differences between the groups are nonsignificant.
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incidental because TNFα and IL1 were not different, as would 
be expected given the lack of increases in the IL6 levels of the 
oxazolone- and vehicle-treated mice. However, because IL6 can 
be secreted by macrophages in response to microbe-associated 
molecular patterns, it represents one of the key pathways through 
which the GM could act on the immune system,51 and increases 
in IL6 frequently are associated with stress.39 Increased IL6 levels 
might have been induced through a very acute reaction in the 
baseline group that was caused by stress associated with terminal 
sampling. The chronic, local inflammation may also have had af-
fected systemic levels of CRP, which were increased in oxazolone-
treated mice. Murine CRP is not a major acute-phase protein but 
is rather a trace protein that is detectable only at very low levels 
even during acute inflammation.44,56 CRP, however, is involved 
in complement binding, macrophage activation, and innate im-
munity, and thus a link to the GM composition still may exist.44 
Although levels of CRP around 45 ng/mL are low,8 chronic un-
predictable stress increases CRP in ApoE knockout mice to levels 
within the same range, but because CRP also increases IL6 lev-
els,57 these 2 parameters are somewhat contradictory.
In conclusion, our study shows that the GM of mice is related 
to the development of oxazolone-induced skin inflammation. 
In addition, generation of the inflammation likely induces a 
pathophysiologic response that alters the GM composition.
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the immense inflammation and pronounced edema in the pinnae 
caused some level of pain and irritation. The GM is believed to 
influence pain perception47 and seems to be necessary for mice 
to develop inflammatory hypernociception.2 Restraint-associated 
stress causes exaggerated increases in ACTH and corticosterone 
levels in germ-free but not SPF mice, and this effect can be re-
versed by monoassociation with a single organism, Bifidobacte-
rium infantis,50 a predominant bacterium in the infant gut and a 
commonly used probiotic organism.40 In addition, it recently was 
demonstrated that mice exposed to a social-disruption stressor 
displayed changes in the composition, diversity, and quantity of 
the GM.3 Hapten-induced ear inflammation in nonobese diabetic 
mice reduces the incidence of type 1 diabetes,14,15 the incidence 
of which also is known to be associated with the GM.7,20,21 The 
mechanism behind this association may be that the dermatitis 
stresses the mice, leading to a change in the GM composition and 
thereby a difference in the incidence of diabetes. Alternatively, in 
the present study, oxazolone itself may have disturbed the bacte-
rial composition in the gastrointestinal tract, for example, via the 
oral route due to cagemates licking each other’s ears.
IL6 was higher in the untreated baseline group compared with 
the oxazolone and vehicle-only groups. This difference may be 
Figure 7. Plasma levels of C-reactive protein (mean ± 1 SD) in plasma of 
nondosed (baseline), vehicle- and oxazolone-dosed mice measured on 
day 21. Plasma C-reactive protein is higher (†, P < 0.01) in the oxazolone 
group.
Table 1. Correlation of initial fecal gastrointestinal microbiota composi-
tion and local cytokine levels in ear tissue from the oxazolone group at 
study termination
IFNγ KC/GRO TNFα IL1β IL2 IL4 IL5 IL10 IL12
r2 0.93 0.88 0.87 0.83 0.07 0.74 0.47 0.86 0.71
P 0.001 0.01 0.01 0.01 ns 0.05a ns 0.01 0.05
ns, nonsignificant.
Regression analysis was performed on the combined principal 
components (PC1, PC2, PC3) of feces from day −7 and correlated against 
cytokine levels in ear tissue on day 21.
aThe significance of the correlation between fecal composition and local 
ear IL4 is questionable, because this significance disappears after 
removal of a random data set; this effect did not occur with any other 
cytokine.
Figure 8. Principal component (PC) analysis plot of cecal gastrointes-
tinal microbiota from nondosed baseline mice (blue bullets), vehicle-
dosed mice (green bullets), and oxazolone-dosed mice (red bullets). 
Clusters representing the oxazolone-treated group differed significantly 
(P < 0.05) from those corresponding to the combined vehicle-only and 
baseline groups on PC1.
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